Clinical Trial Update: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant intratumoral treatment with Daromun is being studied in patients with clinical stage IIIB/IIIC/IIID melanoma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DAROMUN

Snippet

Sponsor: Philogen S.p.A. | Conditions: Melanoma Stage IIIB, Melanoma Stage IIIC | Phase 3 | Status: RECRUITING